WELL Health Technologies Corp. (WELL.TO)
CAD 7.0
(-1.27%)
CAD 7.0
(-1.27%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 101.87 Million CAD | 31.78% |
| 2022 | 95.98 Million CAD | 141.53% |
| 2021 | 21.26 Million CAD | 668.92% |
| 2020 | -495 Thousand CAD | -62.96% |
| 2019 | -4.29 Million CAD | -74.45% |
| 2018 | -2.18 Million CAD | -118.45% |
| 2017 | -905.91 Thousand CAD | -58.15% |
| 2016 | -572.82 Thousand CAD | -1362.62% |
| 2015 | -39.16 Thousand CAD | -11.4% |
| 2014 | -35.15 Thousand CAD | 70.05% |
| 2013 | -117.39 Thousand CAD | -112.6% |
| 2012 | -55.21 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 31.43 Million CAD | 7.87% |
| 2024 Q1 | 21.9 Million CAD | 0.95% |
| 2023 Q1 | 22.24 Million CAD | 48.18% |
| 2023 Q4 | 28.87 Million CAD | 39.68% |
| 2023 FY | - CAD | 31.78% |
| 2023 Q3 | 20.66 Million CAD | -4.47% |
| 2023 Q2 | 21.63 Million CAD | -2.74% |
| 2022 FY | - CAD | 141.53% |
| 2022 Q1 | 19.61 Million CAD | 17.96% |
| 2022 Q2 | 19.46 Million CAD | -0.74% |
| 2022 Q3 | 30.56 Million CAD | 56.98% |
| 2022 Q4 | 15.01 Million CAD | -50.88% |
| 2021 Q1 | -3.85 Million CAD | -69.51% |
| 2021 FY | - CAD | 668.92% |
| 2021 Q4 | 16.62 Million CAD | 28.51% |
| 2021 Q3 | 12.93 Million CAD | 105.64% |
| 2021 Q2 | 6.29 Million CAD | 263.34% |
| 2020 Q3 | -1.69 Million CAD | -40.28% |
| 2020 Q4 | -2.27 Million CAD | -33.77% |
| 2020 Q1 | -443.88 Thousand CAD | 40.01% |
| 2020 Q2 | -1.21 Million CAD | -172.81% |
| 2020 FY | - CAD | -62.96% |
| 2019 Q2 | -822.62 Thousand CAD | -20.21% |
| 2019 FY | - CAD | -74.45% |
| 2019 Q1 | -684.31 Thousand CAD | 0.0% |
| 2019 Q3 | -1.2 Million CAD | -46.55% |
| 2019 Q4 | -739.95 Thousand CAD | 38.62% |
| 2018 Q2 | -603.05 Thousand CAD | -363.85% |
| 2018 Q1 | -130.01 Thousand CAD | 68.26% |
| 2018 Q3 | -897.1 Thousand CAD | -48.76% |
| 2018 FY | - CAD | -118.45% |
| 2017 Q3 | -4.88 Million CAD | -1069.04% |
| 2017 FY | - CAD | -58.15% |
| 2017 Q4 | -409.62 Thousand CAD | 91.61% |
| 2017 Q2 | -417.83 Thousand CAD | -138.85% |
| 2017 Q1 | -174.93 Thousand CAD | -172.9% |
| 2016 Q2 | -133.64 Thousand CAD | 47.58% |
| 2016 Q3 | -153.21 Thousand CAD | -14.64% |
| 2016 Q4 | -64.1 Thousand CAD | 58.16% |
| 2016 FY | - CAD | -1362.62% |
| 2016 Q1 | -254.96 Thousand CAD | -722.33% |
| 2015 Q2 | -9102.00 CAD | 55.84% |
| 2015 FY | - CAD | -11.4% |
| 2015 Q4 | -31 Thousand CAD | -817.58% |
| 2015 Q3 | -3379.00 CAD | 62.88% |
| 2015 Q1 | -20.61 Thousand CAD | 81.62% |
| 2014 Q3 | -9076.00 CAD | -278.8% |
| 2014 Q2 | -2396.00 CAD | 84.82% |
| 2014 Q1 | -15.78 Thousand CAD | -99.91% |
| 2014 Q4 | -112.11 Thousand CAD | -1135.27% |
| 2014 FY | - CAD | 70.05% |
| 2013 Q4 | -7897.00 CAD | 72.95% |
| 2013 Q1 | -35.61 Thousand CAD | -1238.95% |
| 2013 FY | - CAD | -112.6% |
| 2013 Q3 | -29.19 Thousand CAD | 43.11% |
| 2013 Q2 | -51.31 Thousand CAD | -44.08% |
| 2012 Q3 | -46.44 Thousand CAD | -1435.34% |
| 2012 Q4 | -2660.00 CAD | 94.27% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q1 | -12.55 Thousand CAD | -353.39% |
| 2012 Q2 | -3025.00 CAD | 75.91% |
| 2011 Q2 | -96.00 CAD | -252.38% |
| 2011 Q4 | -2770.00 CAD | 0.0% |
| 2011 Q1 | 63.00 CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CareRx Corporation | 25.95 Million CAD | -292.529% |
| dentalcorp Holdings Ltd. | 197.4 Million CAD | 48.391% |
| Extendicare Inc. | 98.61 Million CAD | -3.311% |
| Numinus Wellness Inc. | -26.66 Million CAD | 482.097% |
| Sienna Senior Living Inc. | 112.89 Million CAD | 9.762% |